SCHEMBL11962283

SCHEMBL11962283

c1ccc2c(-c3ccc4ccc5ccc(-c6ccc(Oc7ccc(-c8ccc9ccc%10ccc(-c%11cccc%12ccccc%11%12)nc%10c9n8)cc7)cc6)nc5c4n3)cccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ENPP1 P22413 2/20 0.40
▸ ENPP3 O14638 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ PPARG P37231 7/20 0.38
▸ PPARA Q07869 7/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ PPARD Q03181 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ AR P10275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11962291 0.92 PIM1 (0.39) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL10032245 0.91 ENPP3 (0.46) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL10032339 0.89 ENPP3 (0.45) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL19768245 0.88 ENPP3 (0.44) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL10032442 0.88 ENPP1 (0.48) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL10032343 0.86 ENPP1 (0.47) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL17174051 0.86 PIM1 (0.49) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL11962325 0.86 NPC1 (0.46) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL19768161 0.85 ENPP3 (0.42) PARP1KDM4EALDH1A1NPC1RAB9A
SCHEMBL10032267 0.84 ALDH1A1 (0.50) KDM4EALDH1A1NPC1NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 — — US disclosed
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 — — US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 — — US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 — — US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 — — US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 — — US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 — — US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 — — US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 — — US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FTO, EML4, SLC43A1 PARP1 2955/4885KDM4E 1749/4885ALDH1A1 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback